tyrosine has been researched along with 7,7'-(carbonyl-bis(imino-n-methyl-4,2-pyrrolcarbonylimino(n-methyl-4,2-pyrrol)carbonylimino))-bis(1,3-naphthalenedisulfonic acid) in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ciomei, M; Grandi, M; Mariani, M; Mongelli, N; Pastori, W; Sola, F | 1 |
| Caiolfa, VR; Cohen-Luria, R; Hariharan, C; Parola, AH; Pines, D; Pines, E; Safran, M; Yayon, A; Zamai, M | 1 |
2 other study(ies) available for tyrosine and 7,7'-(carbonyl-bis(imino-n-methyl-4,2-pyrrolcarbonylimino(n-methyl-4,2-pyrrol)carbonylimino))-bis(1,3-naphthalenedisulfonic acid)
| Article | Year |
|---|---|
New sulfonated distamycin A derivatives with bFGF complexing activity.
Topics: 3T3 Cells; Animals; Binding, Competitive; Distamycins; Fibroblast Growth Factor 2; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Phosphorylation; Structure-Activity Relationship; Sulfonic Acids; Suramin; Tyrosine | 1994 |
Nature of Interaction between basic fibroblast growth factor and the antiangiogenic drug 7,7-(carbonyl-bis[imino-N-methyl-4,2-pyrrolecarbonylimino[N-methyl-4,2-pyrrole]-carbonylimino])-bis-(1,3-naphtalene disulfonate). II. Removal of polar interactions af
Topics: Amino Acid Substitution; Angiogenesis Inhibitors; Distamycins; Fibroblast Growth Factor 2; Humans; Kinetics; Models, Molecular; Mutagenesis, Site-Directed; Neovascularization, Physiologic; Protein Conformation; Protein Denaturation; Protein Folding; Thermodynamics; Tryptophan; Tyrosine | 2002 |